Trophos Raises [euro]8.5M To Move Compound Into Phase II Trials.

BioWorld International Correspondent

PARIS - Trophos SA raised C8.5 million (US$11.6 million) in a series C funding round, bringing to C43.5 million the total funding the Marseille, France-based company has raised since it was founded in 1999. That total includes C26.5 million of equity and C12 million of research grants from various sources.

The financing was led by a new investor, OTC Asset Management, of Paris, which was joined by another Paris-based fund, CM-CIC Capital Prive.

Trophos's five existing investors also participated in the funding round: Societe Generale Asset Management (SGAM), of Paris; Viveris Management, of Marseille; Turenne Capital …